ANKRD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.86439999392019E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.76409999941285E-08 |
Normal-vs-Stage2 |
5.183800E-04 |
Normal-vs-Stage3 |
2.64530000126939E-08 |
Normal-vs-Stage4 |
2.97219999945142E-07 |
Stage1-vs-Stage2 |
7.124200E-01 |
Stage1-vs-Stage3 |
2.061800E-01 |
Stage1-vs-Stage4 |
3.062200E-01 |
Stage2-vs-Stage3 |
2.726200E-01 |
Stage2-vs-Stage4 |
3.210600E-01 |
Stage3-vs-Stage4 |
9.141000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.48130002603142E-09 |
Normal-vs-AfricanAmerican |
1.39219746841945E-11 |
Normal-vs-Asian |
1.100150E-02 |
Caucasian-vs-AfricanAmerican |
5.022700E-03 |
Caucasian-vs-Asian |
7.390200E-01 |
AfricanAmerican-vs-Asian |
3.842800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.96440000219422E-09 |
Normal-vs-Female |
5.4704996088617E-10 |
Male-vs-Female |
4.444400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.70980000000177E-05 |
Normal-vs-Age(41-60Yrs) |
3.26939999517606E-08 |
Normal-vs-Age(61-80Yrs) |
2.08249999467114E-08 |
Normal-vs-Age(81-100Yrs) |
7.88849999988628E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.048000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.273200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.041800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.390800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.813420E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.625360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.798300E-04 |
Normal-vs-Grade 2 |
4.68430000344355E-08 |
Normal-vs-Grade 3 |
3.57370000259039E-08 |
Normal-vs-Grade 4 |
1.90009996625662E-09 |
Grade 1-vs-Grade 2 |
2.693200E-01 |
Grade 1-vs-Grade 3 |
4.644400E-01 |
Grade 1-vs-Grade 4 |
7.610400E-01 |
Grade 2-vs-Grade 3 |
9.148800E-01 |
Grade 2-vs-Grade 4 |
3.128200E-02 |
Grade 3-vs-Grade 4 |
3.549700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.99610000049123E-07 |
Normal-vs-ccB subtype |
3.98990000038957E-07 |
ccA subtype-vs-ccB subtype |
5.543600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.9796999994881E-07 |
Normal-vs-N1 |
2.453000E-01 |
N0-vs-N1 |
4.936800E-01 |
|
|